Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Outcome of typhlitis in children with cancer

소아암 환자에서 발생한 막창자염(typhlitis)의 치료성적

  • Lee, Jae Min (Department of Pediatrics, College of Medicine, Yeungnam University) ;
  • Choi, Kwang Hae (Department of Pediatrics, College of Medicine, Yeungnam University) ;
  • Hah, Jeong Ok (Department of Pediatrics, College of Medicine, Yeungnam University)
  • 이재민 (영남대학교 의과대학 소아과학교실) ;
  • 최광해 (영남대학교 의과대학 소아과학교실) ;
  • 하정옥 (영남대학교 의과대학 소아과학교실)
  • Received : 2007.12.04
  • Accepted : 2007.01.19
  • Published : 2008.02.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : Neutropenic enterocolitis is an acute, life-threatening inflammation of the small and large bowel, often seen in children with malignancies during periods of prolonged or severe neutropenia. The optimal management for typhlitis in pediatric oncology patients has been debateful between operative and nonoperative approaches. The purpose of this study was to review the outcome of medical management of patients who were diagnosed as typhlitis. Methods : The records of 207 pediatric cancer patients who were diagnosed and treated at the pediatric department of Yeungnam University Hospital for cancer between August, 2002 and July, 2007 were reviewed. Results : Among 207 patients, 12 (5.7%) children aged 9 to 14 years, were diagnosed clinically to have typhlitis. Clinical symptoms and signs of patients were fever, abdominal pain and tenderness, diarrhea, vomiting and rebound tenderness. Bowel-wall thickening (> 4mm) was seen on CT or ultrasonography. All patients were treated with antibiotics combinations of teicoplanin, carbapenem, aminoglycoside, or other third generation cephalosporin and metronidazole or clindamycin. Eight patients were treated with additional antifungal agents. Other supportive management included bowel rest, total parenteral nutrition, and G-CSF administration. All patients recovered completely and did not need any surgical management. Conclusion : Early diagnosis and aggressive supportive treatment appears to be important for complete recovery and survival of typhlitis.

목 적 : 막창자염은 면역기능이 저하되고 호중구가 감소된 소아암 환자에서 호발하는 괴사성 장염으로 사망률이 매우 높은 것으로 알려져 있다. 저자들은 항암치료 중 발생한 막창자염에 대하여 적극적인 내과적 치료와 항생제 치료를 시행하여 그 치료성적을 분석하고자 본 연구를 시행하였다. 방 법 : 2002년 8월부터 2007년 7월까지 영남대학교병원 소아과에 입원하여 항암화학요법을 받은 소아암 환자 207명 중 막창자염으로 진단받은 12명을 대상으로 의무기록을 분석하였다. 진단은 임상증상과 신체검진소견, 복부단순촬영검사, 복부초음파검사와 복부전산화단층촬영으로 하였다. 항암화학요법 시행 후 증상 발생일, 백혈구수, 절대호중구수, 치료항생제의 종류 및 치료기간과 치료결과를 분석하였다. 결 과 : 막창자염으로 임상적 진단을 받은 환자는 12명(5.7%)이었으며, 임상증상은 복부통증 및 압통 12명(100%), 발열 12명(100%), 설사 9명(75%), 구토 5명(41%), 반발압통 3명(25%) 등이었다. 항암화학요법 종료일로부터 증상 발생일까지의 기간의 중앙값은 12일(범위 3-18일)이었다. 백혈구수의 중앙값은 340 / L$(30-1,270/{\mu}L)$이었으며, 절대호중구수의 중앙값은 $116/{\mu}L(0-648/{\mu}L$)이었다. 치료는 항생제 요법과 충분한 수분 공급 및 장의 휴식 등 보존적 요법을 시행하였으며 환자 12명 모두 증상이 호전되었고, 수술적 치료를 받은 경우는 없었다. 항생제 조합의 선택에 따른 항생제 사용기간의 통계적인 차이는 없었다(P=0.74). 결 론 : 항암화학요법을 받는 소아암 환자에서 발열, 우하복부 압통, 호중구감소증이 있을 때는 막창자염을 의심하여야 하며, 조기진단 및 적극적인 내과적 치료와 항생제 요법을 시행하여 좋은 결과를 얻을 수 있다고 생각된다.

Keywords

References

  1. Katz JA, Wagner ML, Gresik MV, Mahonev DH Jr, Fernbach DJ. Typhlitis. An 18-year experience and postmortem review. Cancer 1990;65:1041-7 https://doi.org/10.1002/1097-0142(19900215)65:4<1041::AID-CNCR2820650433>3.0.CO;2-A
  2. Davila ML. Neutropenic enterocolitis: current issues in diagnosis and management. Curr Infect Dis Rep 2007;9:116-20 https://doi.org/10.1007/s11908-007-0006-3
  3. McCarville MB, Adelman CS, Li C, Xiong X, Furman WL, Razzouk BI, et al. Typhlitis in childhood cancer. Cancer 2005;104:380-7 https://doi.org/10.1002/cncr.21134
  4. Otaibi AA, Barker C, Anderson R, Sigalet DL. Neutropenic enterocolitis (typhlitis) after pediatric bone marrow transplant. J Pediatr Surg 2002;37:770-2 https://doi.org/10.1053/jpsu.2002.32274
  5. Davila ML. Neutropenic enterocolitis. Curr Opin Gastroenterol 2006;22:44-7
  6. Shamberger RC, Weinstein HJ, Delorey MJ, Levey RH. The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia. Cancer 1986;57:603-9 https://doi.org/10.1002/1097-0142(19860201)57:3<603::AID-CNCR2820570335>3.0.CO;2-K
  7. Kim PW, Ji HG, Jeong HS, Moon CI, Yang DK, Lee SW, et al. Four cases of typhlitis, developed in neutropenic state and treated with medical conservative management. J Korean Cancer Assoc 1997;29:906-13
  8. Gorschluter M, Mey U, Strehl J, Ziske C, Schepke M, Schmidt-Wolf IG, et al. Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Haematol 2005;75:1-13 https://doi.org/10.1111/j.1600-0609.2005.00442.x
  9. Wagner ML, Rosenberg HS, Fernbach DJ, Singleton EB. Typhlitis: a complication of leukemia in childhood. Am J Roentgenol Radium Ther Nucl Med 1970;109:341-50 https://doi.org/10.2214/ajr.109.2.341
  10. Moir DH, Bale PM. Necropsy findings in childhood leukaemia, emphasizing neutropenic enterocolitis and cerebral calcification. Pathology 1976;8:247-58 https://doi.org/10.3109/00313027609059005
  11. Kang WK, Kim SD, Kim HJ, Cho HM, Park SC, Jeon HM, et al. Right lower quadrant pain in patients with acute myeloid leukemia. J Korean Surg Soc 2004;66:420-3
  12. Park SM, Ha IS, Lee HJ, Seo JK, Ahn HS, Yeon KM. Three cases of typhlitis during treatment for acute myelocytic leukemia in children. J Korean Pediatr Soc 1989;32:1445-62
  13. Sloas MM, Flynn PM, Kaste SC, Patrick CC. Typhlitis in children with cancer: a 30-year experience. Clin Infect Dis 1993;17:484-90 https://doi.org/10.1093/clinids/17.3.484
  14. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-51 https://doi.org/10.1086/339215
  15. Rifkin GD. Neutropenic enterocolitis and clostridium septicum infection in patients with agranulocytosis. Arch Intern Med 1980;140:834-5 https://doi.org/10.1001/archinte.140.6.834
  16. Pouwels MJ, Donnelly JP, Raemaekers JM, Verweij PE, de Pauw BE. Clostridium septicum sepsis and neutropenic enterocolitis in a patient treated with intensive chemotherapy for acute myeloid leukemia. Ann Hematol 1997;74:143-7 https://doi.org/10.1007/s002770050273
  17. Barie PS, Vogel SB, Dellinger EP, Rotstein OD, Solomkin JS, Yang JY, et al. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group. Arch Surg 1997;132:1294-302 https://doi.org/10.1001/archsurg.1997.01430360040008
  18. Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, et al. Infectious Diseases Society of America. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003;37:997-1005 https://doi.org/10.1086/378702
  19. Gorschluter M, Mey U, Strehl J, Schmitz V, Rabe C, Pauls K, et al. Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients. BMC Infect Dis[100968551] 2006;6:35. Available from:URL://http://www.biomedcentral.com/1471-2334/6/35 https://doi.org/10.1186/1471-2334-6-35
  20. NCCN practice guidelines for fever and neutropenia. National Comprehensive Cancer Network. Oncology (Williston Park) 1999;13:197-257
  21. Seo SG, Park GS, Kim HS, Kang CM. Three cases of typhlitis in children with aplastic anemia and acute leukemia. Korean J Pediatr Hematol Oncol 1995;2:135-40
  22. Schlatter M, Snyder K, Freyer D. Successful nonoperative management of typhlitis in pediatric oncology patients. J Pediatr Surg 2002;37:1151-5 https://doi.org/10.1053/jpsu.2002.34461